⌘K

Home/Filings/4/0001209191-19-005132

4//SEC Filing

FARNAM JOHN 4

Accession 0001209191-19-005132

CIK 0001422143other

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:10 PM ET

Size

5.4 KB

Accession

0001209191-19-005132

Insider Transaction Report

Form 4

Period: 2019-01-22

Kura Oncology, Inc.KURA

Chief Operating Officer

Transactions

Award
Option to purchase common stock
2019-01-22+125,000→ 125,000 total
Exercise: $15.47Exp: 2029-01-21→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]This option vests in 48 equal monthly installments commencing on the grant date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1

filerCIK 0001744376

Filing Metadata

Form type: 4
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 4:10 PM ET
Size: 5.4 KB

View on SEC.gov